The Valley Desk

NCT00577473 · Interventional trial

Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)

Overall registry status Completed

Phase 3

Conditions Ulcerative Colitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov